At Toxikon, we are dedicated to collaborating with you and your suppliers to ensure that the products you develop are effective and safe. We deliver exceptional expertise and service that is timely, efficient and cost-effective. 

Connect With Us

    

Our Services

 News & Events   

  • Toxikon to Exhibit at MEDevice San Diego - Sept 1,2 »more
  • Toxikonto Exhibit and Present at PharmaEd Resources in Philly - Sept 14,15 »more
  • Toxikon to Present and Exhibit at Medical Grade Polymers 2015 in Woburn - Sept 15,16 »more
  • Toxikon to Present and Exhibit at ManuBIO in Boston - Sept 23,24 »more
  • Toxikon to Exhibit at ASR 31st Annual Meeting in North Carolina - Oct 8-10 »more
  • Toxikon to give Joint US-Europe Presentation at Symbioteq Biocompatibility of Medical Devices 2015 Conference in Sweden Oct 13-14 »more
  • Toxikon to Exhibit at MD&M Minneapolis - Nov 4,5 »more
  • Toxikon to Exhibit at BIOMEDevice San Jose - Dec 2,3 »more
Link to Toxikon Belgium Site
Preclinical CRO | Preclinical Development Services from Concept to
toxicology (acute, subchronic, and chronic toxicity, reproductive toxicity, genetic toxicology, and carcinogenicity), pharmacokinetics, toxicokinetics, bioavailability, ADME, chemical characterization, impurities analysis and synthesis, bioanalytical, and microbiology/virology, pharmaceutical, medical device, or biotech company, anticancer or antiviral compound, ocular studies, ophthalmic, disease models, Analytical and Bioanalytical Chemistry, Biocompatibility Assessment, biocompatibility Safety Evaluation Guidelines, Cell and Molecular Biology, Disease Models, Efficacy and Surgical Research Services, Extractables and Leachables, microbiology Ocular Drug Program Pathology R&D and Discovery
Toxikon is a preclinical contract research organization (CRO) dedicated to collaborating with biotech, pharmaceutical and medical device researchers to deliver exceptional drug research and development services from concept to final product.